Correction Volume 12, Issue 5 pp 4678—4679
Correction for: ciRs-6 upregulates March1 to suppress bladder cancer growth by sponging miR-653
- 1 The Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
- 2 The Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
- 3 The Department of Gynecological oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
- 4 The Department of Urology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China
- 5 The Department of Thyroid Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
- 6 The Department of Pediatric Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
received: February 19, 2020 ; accepted: March 27, 2020 ; published: March 2, 2020 ;https://doi.org/10.18632/aging.102885
How to Cite
Copyright © 2020 Su et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been corrected: The authors requested the replacement of Figure 4E and Table 1. Figure 4E (ciRs-6+miR-nc) was quite similar to Supplementary Figure 1D (si-3 in T24 cells) and was slightly updated. Changes of Table 1 are done to correct the statistical mistakes.
These corrections do not change the content of the publication and do not affect the conclusion of this research. The authors apologize for the unintentional mistakes.
The corrected Figure and Table are provided below.
Table 1. Relationship between ciRs-6 level and clinical characteristics in bladder cancer.
|Total||Patients||Expression of ciRs-6|
|Number of tumors|
|Lymph node metastasis|
|Follow-up (month, mean)||33.23||33.00||33.45||0.047|